Journal
JOURNAL OF WOUND CARE
Volume 28, Issue 6, Pages 370-382Publisher
MA HEALTHCARE LTD
DOI: 10.12968/jowc.2019.28.6.370
Keywords
bacterial bioburden; chronic wound; dialkylcarbamoyl chloride (DACC); infection; Sorbact; surgical site infection
Categories
Funding
- ABIGO Medical
Ask authors/readers for more resources
The aim of this review was to present the clinical data on the use of the family of bacterial-binding dressings (Sorbact; dialkylcarbamoyl chloride-coated) in the treatment of a variety of acute and chronic wounds. The findings are discussed in terms of the effectiveness of the bacterial-binding dressings on bacterial bioburden reduction, infection prevention, initiation/ progression of wound healing and cost-effectiveness. The evidence in support of the bacterial-binding dressings is strongest in the area of infection prevention in surgical wounds, with several controlled trials showing the prophylactic benefit of the dressing in these wounds. Wound bioburden management in chronic wounds is supported by a number of clinical studies. In total, 29 published clinical studies (with a total of 4044 patients) were included in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available